Contact
Please use this form to send email to PR contact of this press release:
Patient Enrollment Concluded Early in PEGASUS Phase 3 Pemphigus Trial for Rilzabrutinib
TO:
Please use this form to send email to PR contact of this press release:
Patient Enrollment Concluded Early in PEGASUS Phase 3 Pemphigus Trial for Rilzabrutinib
TO: